Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-Site, Double-Blind, Flexible-Dose, Placebo-Controlled Study of the Efficacy, Tolerability, & Safety of Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS)

NCT00610909 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00610909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Single-Site, Double-Blind, Flexible-Dose, Placebo-Controlled Study of the Efficacy, Tolerability, & Safety of Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS)
Lead sponsor
Duke University
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2002
Completion date
December 31, 2002
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.